Literature DB >> 23741077

A new strategy for the synthesis of β-benzylmercaptoethylamine derivatives.

Subrata Ghosh1, Gregory P Tochtrop.   

Abstract

Here we describe a new experimental approach to the synthesis of the β-benzylmercaptoethylamine functionality and illustrate its synthetic utility in multi-component reactions. Although prevalent in modern organic synthesis, no general methods have been described for this functionality. Using a carefully developed LiOH-water-ethanol reaction mixture we were able to produce a diverse collection of β-benzylmercaptoethylamines containing a range of sensitive functional groups in excellent yields. To further illustrate their utility in molecular library synthesis, we also report the use of β-benzylmercaptoethylamines in five different multi-component reactions.

Entities:  

Year:  2009        PMID: 23741077      PMCID: PMC3670100          DOI: 10.1016/j.tetlet.2009.01.133

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  30 in total

1.  Synthesis of the PPARbeta/delta-selective agonist GW501516 and C4-thiazole-substituted analogs.

Authors:  Raquel Pereira; Claudine Gaudon; Beatriz Iglesias; Pierre Germain; Hinrich Gronemeyer; Angel R de Lera
Journal:  Bioorg Med Chem Lett       Date:  2005-10-18       Impact factor: 2.823

2.  Small and neutral Tc(v)O BAT, bisaminoethanethiol (N2S2) complexes for developing new brain imaging agents.

Authors:  S Oya; K Plössl; M P Kung; D A Stevenson; H F Kung
Journal:  Nucl Med Biol       Date:  1998-02       Impact factor: 2.408

3.  Synthesis and biological evaluation of new thiazolyl/benzothiazolyl-amides, derivatives of 4-phenyl-piperazine.

Authors:  Christina Papadopoulou; Athina Geronikaki; Dimitra Hadjipavlou-Litina
Journal:  Farmaco       Date:  2005-07-22

4.  Synthesis and histamine H2-agonistic activity of ring-substituted phenyl analogues of impromidine.

Authors:  A Buschauer; F Lachenmayr; W Schunack
Journal:  Pharmazie       Date:  1991-12       Impact factor: 1.267

Review 5.  Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries.

Authors:  M A Gallop; R W Barrett; W J Dower; S P Fodor; E M Gordon
Journal:  J Med Chem       Date:  1994-04-29       Impact factor: 7.446

6.  The use of the Ugi four-component condensation.

Authors:  Stefano Marcaccini; Tomás Torroba
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.

Authors:  Seiji Miwatashi; Yasuyoshi Arikawa; Etsuo Kotani; Maki Miyamoto; Ken-Ichi Naruo; Hiroyuki Kimura; Toshimasa Tanaka; Satoru Asahi; Shigenori Ohkawa
Journal:  J Med Chem       Date:  2005-09-22       Impact factor: 7.446

8.  Zirconium(IV) compounds as efficient catalysts for synthesis of alpha-aminophosphonates.

Authors:  Srikant Bhagat; Asit K Chakraborti
Journal:  J Org Chem       Date:  2008-06-25       Impact factor: 4.354

9.  Synthesis of 2,4-disubstituted thiazoles and selenazoles as potential antitumor and antifilarial agents: 1. Methyl 4-(isothiocyanatomethyl)thiazole-2-carbamates, -selenazole-2- carbamates, and related derivatives.

Authors:  Y Kumar; R Green; K Z Borysko; D S Wise; L L Wotring; L B Townsend
Journal:  J Med Chem       Date:  1993-11-26       Impact factor: 7.446

10.  Stereoselective synthesis of phosphoramidate alpha(2-6)sialyltransferase transition-state analogue inhibitors.

Authors:  Danielle Skropeta; Ralf Schwörer; Richard R Schmidt
Journal:  Bioorg Med Chem Lett       Date:  2003-10-06       Impact factor: 2.823

View more
  1 in total

1.  Molecular docking-assisted investigation of Pd(II) complexes carrying "SNS" pincer-type pyridine-thioether ligand as potential drug candidates against COVID-19.

Authors:  Hatice Gamze Sogukomerogullari
Journal:  Comput Biol Med       Date:  2022-04-10       Impact factor: 6.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.